Trials / Completed
CompletedNCT02949453
ACCeptation and Qualitative Evaluation of Phone-delivered Intervention
ACCeptation and Qualitative Evaluation of Phone-delivered Intervention To Prevent Suicide Reattempt
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Hôpital le Vinatier · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Background: Previous suicide attempt is known to be a strong risk factor for repetition and repetition is common within the first year after an episode of deliberate self-harm (DSH). There has been growing interest in brief interventions for this population that are focused on maintaining long-term contact and/or offering re-engagement with services when needed. Despite telephone-delivered interventions have shown promising results in suicide reattempt prevention, subjective impact of such brief contact interventions and effectiveness mechanisms have never been evaluated.
Detailed description
Semi-structured in-depth interviews with 20 patients previously receiving a telephone-delivered intervention from our team. Six weeks and 3 months after a DSH, people included in telephone-delivered process will be interviewed by a social science researcher. Qualitative analysis using thematic analysis will be independently performed by two researchers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Semi-directed interview performed by a social sciences researcher | Two semi-directed interviews performed by social sciences researcher: * first interview performed 6 weeks after the suicide attempt, in an suicide prevention unit, duration 1 to 1.5 hour * second interview performed 3 month after the suicide attempt, in a suicide prevention unit, duration 1 to 1.5 hour |
Timeline
- Start date
- 2017-03-03
- Primary completion
- 2019-04-04
- Completion
- 2019-04-04
- First posted
- 2016-10-31
- Last updated
- 2019-04-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02949453. Inclusion in this directory is not an endorsement.